Item Type | Name |
Academic Article
|
A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis.
|
Academic Article
|
Follow-up survey of 308-nm laser treatment of psoriasis.
|
Academic Article
|
Patients with psoriasis prefer solution and foam vehicles: a quantitative assessment of vehicle preference.
|
Academic Article
|
Remissions of psoriasis with excimer laser treatment.
|
Academic Article
|
Psoriasis treatment 2003 at the new millennium: position paper on behalf of the authors.
|
Academic Article
|
The design of clinical trials in psoriasis: lessons for clinical practice.
|
Academic Article
|
Case studies in severe psoriasis: A clinical strategy.
|
Academic Article
|
Modest innovations in psoriasis treatment?
|
Academic Article
|
Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use.
|
Academic Article
|
The promise and challenge of new biological treatments for psoriasis: how do they impact quality of life?
|
Academic Article
|
Determinants of quality of life in patients with psoriasis: a study from the US population.
|
Academic Article
|
Tacrolimus ointment is effective for facial and intertriginous psoriasis.
|
Academic Article
|
A Simplified Psoriasis Area Severity Index (SPASI) for rating psoriasis severity in clinic patients.
|
Academic Article
|
The cost of psoriasis therapies: considerations for therapy selection.
|
Academic Article
|
Systemic therapy does not usually clear psoriasis, but treatment success does not require clearing.
|
Academic Article
|
Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment.
|
Academic Article
|
Definitions of measures of effect duration for psoriasis treatments.
|
Academic Article
|
The impact of biologics on the quality of life of psoriasis patients and the economics of psoriasis care.
|
Academic Article
|
Involving the patient: impact of inflammatory skin disease and patient-focused care.
|
Academic Article
|
Limited availability of psoriasis and phototherapy care: an analysis of advertisements.
|
Academic Article
|
Inpatient management of severe psoriasis.
|
Academic Article
|
Etanercept improves the health-related quality of life of patients with psoriasis: results of a phase III randomized clinical trial.
|
Academic Article
|
Cutaneous symptoms of dermatomyositis significantly impact patients' quality of life.
|
Academic Article
|
Intermittent dosing of biologics for psoriasis.
|
Academic Article
|
The negative impact of psoriasis on the workplace.
|
Academic Article
|
Psoriasis treatment in the United States at the end of the 20th century.
|
Academic Article
|
Quality of life in patients with psoriasis.
|
Academic Article
|
Novel combination regimens: biologics and acitretin for the treatment of psoriasis-- a case series.
|
Academic Article
|
Critical factors determining the potency of topical corticosteroids.
|
Academic Article
|
The utility of a data-logging device for measuring adherence to home phototherapy.
|
Academic Article
|
Adverse events from systemic therapies for psoriasis are common in clinical practice.
|
Academic Article
|
Medication adherence and health care costs associated with biologics in Medicaid-enrolled patients with psoriasis.
|
Academic Article
|
Poor adherence to treatments: a fundamental principle of dermatology.
|
Academic Article
|
Do utilization management controls for phototherapy increase the prescription of biologics?
|
Academic Article
|
Eligibility creep: a cause for placebo group improvement in controlled trials of psoriasis treatments.
|
Academic Article
|
Conversion to positive tuberculosis test during etanercept treatment of psoriasis.
|
Academic Article
|
Cost-effectiveness of biologic treatments for psoriasis based on subjective and objective efficacy measures assessed over a 12-week treatment period.
|
Academic Article
|
A role for denial in poor adherence to psoriasis treatment.
|
Academic Article
|
Effectiveness of clobetasol propionate spray 0.05% added to other stable treatments: add-on therapy in the COBRA trial.
|
Academic Article
|
Open label trial of alefacept in palmoplantar pustular psoriasis.
|
Academic Article
|
Adherence to acitretin and home narrowband ultraviolet B phototherapy in patients with psoriasis.
|
Academic Article
|
Severity levels in psoriasis: a separate 'very severe' category not required.
|
Academic Article
|
Psoriasis: improving adherence to topical therapy.
|
Academic Article
|
Increasing use of more potent treatments for psoriasis.
|
Academic Article
|
Tanning beds as an alternative for psoriasis when office-based phototherapy is not accessible.
|
Academic Article
|
Equating topical treatment of severe psoriasis to keeping money in a mattress.
|
Academic Article
|
Case report: Fluocinonide-induced perioral dermatitis in a patient with psoriasis.
|
Academic Article
|
Calcitriol ointment: a review of a topical vitamin D analog for psoriasis.
|
Academic Article
|
Paradoxical effects of cost reduction measures in managed care systems for treatment of severe psoriasis.
|
Academic Article
|
Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents.
|
Academic Article
|
Conversations on psoriasis--what patients want and what physicians can provide: a qualitative look at patient and physician expectations.
|
Academic Article
|
Prior authorization for topical psoriasis treatments: is it cost-beneficial for managed care?
|
Academic Article
|
Rheumatologists' recommendations on what to do in the dermatology office to evaluate and manage psoriasis patients' joint symptoms.
|
Academic Article
|
Clobetasol propionate spray 0.05% add-on therapy to a stable regimen of biologic treatment in patients with moderate to very severe plaque psoriasis.
|
Academic Article
|
Factors affecting sleep quality in patients with psoriasis.
|
Academic Article
|
Psoriasis and its treatment with adalimumab.
|
Academic Article
|
Placebo response?
|
Academic Article
|
Trends in home phototherapy adoption in the US: monetary disincentives are only the tip of the iceberg.
|
Academic Article
|
Approaching psoriasis differently: patient-physician relationships, patient education and choosing the right topical vehicle.
|
Academic Article
|
Psoralen plus ultraviolet A light phototherapy effectiveness.
|
Academic Article
|
Review of home phototherapy.
|
Academic Article
|
Medication use and associated health care outcomes and costs for patients with psoriasis in the United States.
|
Academic Article
|
Acitretin in dermatology: a review.
|
Academic Article
|
A pharmacoeconomic analysis of severe psoriasis therapy: a review of treatment choices and cost efficiency.
|
Academic Article
|
Comparing the lifetime risks of TNF-alpha inhibitor use to common benchmarks of risk.
|
Academic Article
|
Efficacy of low-dose acitretin in the treatment of psoriasis.
|
Academic Article
|
Trends in pediatric psoriasis outpatient health care delivery in the United States.
|
Academic Article
|
Tattoo sites and psoriasis.
|
Academic Article
|
A review of protocols for 308 nm excimer laser phototherapy in psoriasis.
|
Academic Article
|
Consensus guidelines for the management of plaque psoriasis.
|
Academic Article
|
Efficacy and safety of calcipotriene 0.005% foam for the treatment of plaque-type psoriasis: results of two multicenter, randomized, double-blind, vehicle-controlled, phase III clinical trials.
|
Academic Article
|
Apremilast as a treatment for psoriasis.
|
Academic Article
|
JAK inhibitors in psoriasis: a promising new treatment modality.
|
Academic Article
|
Trends in older adult psoriasis outpatient health care practices in the United States.
|
Academic Article
|
Interleukin-23 and interleukin-17: importance in pathogenesis and therapy of psoriasis.
|
Academic Article
|
Risk of cardiovascular disorders in psoriasis patients: current and future.
|
Academic Article
|
Sleep disturbances in psoriasis.
|
Academic Article
|
A multicenter, randomized, double-blind study of the efficacy and safety of calcipotriene foam, 0.005%, vs vehicle foam in the treatment of plaque-type psoriasis of the scalp.
|
Academic Article
|
Phototherapy utilization for psoriasis is declining in the United States.
|
Academic Article
|
Efficacy of the 308-nm excimer laser for treatment of psoriasis: results of a multicenter study.
|
Academic Article
|
Psoriasis and pregnancy.
|
Academic Article
|
Use of transcutaneous nerve stimulation wristband to treat methotrexate-induced nausea.
|
Academic Article
|
Treatment of psoriasis in children: is there a role for antibiotic therapy and tonsillectomy?
|
Academic Article
|
A systematic review of adverse effects associated with topical treatments for psoriasis.
|
Academic Article
|
Patients' vehicle preference for corticosteroid treatments of scalp psoriasis.
|
Academic Article
|
The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis.
|
Academic Article
|
Patients with palmoplantar psoriasis have more physical disability and discomfort than patients with other forms of psoriasis: implications for clinical practice.
|
Academic Article
|
Strategy to manage the treatment of severe psoriasis: considerations of efficacy, safety and cost.
|
Academic Article
|
Combination therapy to treat moderate to severe psoriasis.
|
Academic Article
|
Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction.
|
Academic Article
|
A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis.
|
Academic Article
|
Medication and health care service utilization related to depressive symptoms in older adults with psoriasis.
|
Academic Article
|
The prevalence of psoriasis in African Americans: results from a population-based study.
|
Academic Article
|
Medication-related factors affecting health care outcomes and costs for patients with psoriasis in the United States.
|
Academic Article
|
Members of the national psoriasis foundation: more extensive disease and better informed about treatment options.
|
Academic Article
|
Treatments for mild-to-moderate recalcitrant plaque psoriasis: expected clinical and economic outcomes for first-line and second-line care.
|
Academic Article
|
Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial.
|
Academic Article
|
Traditional systemic treatments have not fully met the needs of psoriasis patients: results from a national survey.
|
Academic Article
|
Tazarotene cream (0.1%) in combination with betamethasone valerate foam (0.12%) for plaque-type psoriasis.
|
Academic Article
|
Decision points for the initiation of systemic treatment for psoriasis.
|
Academic Article
|
The frequent use of oral retinoids in combination with other treatments for psoriasis: a retrospective analysis.
|
Academic Article
|
Clobetasol propionate lotion, an efficient and safe alternative to clobetasol propionate emollient cream in subjects with moderate to severe plaque-type psoriasis.
|
Academic Article
|
A reappraisal of the concept of suppressive versus remittive psoriasis treatments.
|
Academic Article
|
Proven efficacy of tacrolimus for facial and intertriginous psoriasis.
|
Academic Article
|
Biologic therapy for psoriasis: telephone triage.
|
Academic Article
|
Factors affecting prescription of ultra-high potency topical corticosteroids in skin disease: an analysis of US national practice data.
|
Academic Article
|
The skinny on psoriasis and obesity.
|
Academic Article
|
Infliximab for inpatient psoriasis management--is there a role?
|
Academic Article
|
The comorbid state of psoriasis patients in a university dermatology practice.
|
Academic Article
|
The role of commercial tanning beds and ultraviolet A light in the treatment of psoriasis.
|
Academic Article
|
Cost-effectiveness of moderate-to-severe psoriasis treatment.
|
Academic Article
|
Home ultraviolet B phototherapy: a cost-effective option for severe psoriasis.
|
Academic Article
|
The cost-effectiveness and cost of treatment failures associated with systemic psoriasis therapies.
|
Academic Article
|
New treatments for psoriasis: which biologic is best?
|
Academic Article
|
Clobetasol propionate for psoriasis: are ointments really more potent?
|
Academic Article
|
Would elimination of copayments for phototherapy decrease the cost of treating psoriasis with systemic biologics? A cost analysis.
|
Academic Article
|
Low-dose acitretin is associated with fewer adverse events than high-dose acitretin in the treatment of psoriasis.
|
Academic Article
|
Nonlaser UVB-targeted phototherapy treatment of psoriasis.
|
Academic Article
|
Death from psoriasis: representative US data.
|
Academic Article
|
Trends in on and off-label calcipotriene use.
|
Academic Article
|
A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis.
|
Academic Article
|
Resident education: effect of the sixth national psoriasis foundation chief residents' meeting.
|
Academic Article
|
Misunderstandings.
|
Academic Article
|
The role of topical therapy for patients with extensive psoriasis.
|
Academic Article
|
Outcomes associated with the use of biologic agents in moderate to severe psoriasis.
|
Academic Article
|
Adherence to topical therapy increases around the time of office visits.
|
Academic Article
|
Does cost-effectiveness play a role in clinical trials?
|
Academic Article
|
Measures used in specifying psoriasis lesion(s), global disease and quality of life: a systematic review.
|
Academic Article
|
Interleukin-12, interleukin-23, and psoriasis: current prospects.
|
Academic Article
|
Targeted UV therapy in the treatment of psoriasis.
|
Academic Article
|
To test or not to test? An evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis.
|
Academic Article
|
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.
|
Academic Article
|
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics.
|
Academic Article
|
The distress of psoriasis doesn't necessarily imply good treatment adherence: a lesson from the treatment of sexually transmitted disease.
|
Academic Article
|
'Coral reef' psoriasis: a marker of resistance to topical treatment.
|
Academic Article
|
Home narrowband UV-B phototherapy in combination with low-dose acitretin in patients with moderate to severe psoriasis.
|
Academic Article
|
Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: results from a randomized, controlled Phase III study.
|
Academic Article
|
What the National Psoriasis Foundation means to dermatologists and our patients.
|
Academic Article
|
Utilization pattern of etanercept and its cost implications in moderate to severe psoriasis in a managed care population.
|
Academic Article
|
Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies.
|
Academic Article
|
Keratolytics for psoriasis: are they necessary?
|
Academic Article
|
Methotrexate: understanding the risk in psoriasis patients.
|
Academic Article
|
Continued use of home narrowband ultraviolet B light phototherapy for psoriasis after completion of a clinical trial.
|
Academic Article
|
Management of psoriasis.
|
Academic Article
|
Literature is lacking in discussion of non-adherence in dermatology.
|
Academic Article
|
Are ointments better than other vehicles for corticosteroid treatment of psoriasis?
|
Academic Article
|
Efficacy of systemic treatments for moderate to severe plaque psoriasis: systematic review and meta-analysis.
|
Academic Article
|
Many new options for improving patients' care.
|
Academic Article
|
Management and costs of severe psoriasis: the role of new biologics.
|
Academic Article
|
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy.
|
Academic Article
|
Topical clobetasol propionate in the treatment of psoriasis: a review of newer formulations.
|
Academic Article
|
A review of home phototherapy for psoriasis.
|
Academic Article
|
Economic evaluation of biologic therapies for the treatment of moderate to severe psoriasis in the United States.
|
Academic Article
|
Efficacy and safety of ustekinumab and etanercept for the treatment of psoriasis.
|
Academic Article
|
Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial.
|
Academic Article
|
Insight into psoriasis management: commercial perspectives for the U.S. psoriasis market.
|
Academic Article
|
Adherence to treatment: still the forgotten variable.
|
Academic Article
|
Optimizing topical therapies for treating psoriasis: a consensus conference.
|
Academic Article
|
Treatment of moderate-to-severe psoriasis with alefacept for up to one year: a case series.
|
Academic Article
|
Cost per responder analysis of ustekinumab and etanercept for moderate to severe plaque psoriasis.
|
Academic Article
|
Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions.
|
Academic Article
|
Commentary: psoriasis patients with a history of malignancy represent an important but overlooked study population.
|
Academic Article
|
Is concomitant use of methotrexate and oral retinoids dangerous? A review of the data regarding this combination.
|
Academic Article
|
A review of phototherapy protocols for psoriasis treatment.
|
Academic Article
|
Acitretin for the treatment of psoriasis: an assessment of national trends.
|
Academic Article
|
A review of targeted ultraviolet B phototherapy for psoriasis.
|
Academic Article
|
Topical drug delivery systems in dermatology: a review of patient adherence issues.
|
Academic Article
|
Comparative efficacy of biologics in psoriasis: a review.
|
Academic Article
|
Therapeutic modalities for localized psoriasis: 308-nm UVB excimer laser versus nontargeted phototherapy.
|
Academic Article
|
Combination therapy in psoriasis: an evidence-based review.
|
Academic Article
|
Psoriasis and cardiovascular screening rates in the United States.
|
Academic Article
|
Infections associated with the use of tumor necrosis factor-a inhibitors in psoriasis.
|
Concept
|
Psoriasis
|
Academic Article
|
Patients' educational needs about topical treatments for psoriasis.
|
Academic Article
|
Combination therapy for psoriasis in the United States.
|
Academic Article
|
Using Hawthorne effects to improve adherence in clinical practice: lessons from clinical trials.
|
Academic Article
|
The effect of folate supplementation on methotrexate efficacy and toxicity in psoriasis patients and folic acid use by dermatologists in the USA.
|
Academic Article
|
Cost effectiveness of biologic therapies for plaque psoriasis.
|
Academic Article
|
Acitretin prescribing patterns in women of childbearing potential.
|
Academic Article
|
The continued evolution of drugs for psoriasis.
|
Academic Article
|
A double-blind, randomized clinical trial of 20% alpha/poly hydroxy acid cream to reduce scaling of lesions associated with moderate, chronic plaque psoriasis.
|
Academic Article
|
Patterns of vitamin D analog use for the treatment of psoriasis.
|
Academic Article
|
Department of Dermatology was blessed with a wonderful psoriasis specialist. Foreword.
|
Academic Article
|
Tachyphylaxis to topical glucocorticoids; what is the evidence?
|
Academic Article
|
Adherence to adalimumab in patients with moderate to severe psoriasis.
|
Academic Article
|
Prevalence of psoriasis and rosacea comorbidities in the outpatient setting.
|
Academic Article
|
Adherence to ustekinumab in psoriasis patients.
|
Academic Article
|
Psoriasis treatments by payment type in the US outpatient office setting.
|
Academic Article
|
Using a single product (calcipotriene/betamethasone topical suspension) vs multiple products to manage body and scalp psoriasis: comparisons in resource utilization and costs.
|
Academic Article
|
Predicting improvement in signs and symptoms of plaque psoriasis after 1 week of treatment with clobetasol propionate 0.05% spray.
|
Academic Article
|
Research gaps in psoriasis: opportunities for future studies.
|
Academic Article
|
Considerable variation among Iranian dermatologists in the dosing and monitoring of methotrexate for treating psoriasis.
|
Academic Article
|
Safety and tolerability of tumor necrosis factor-a inhibitors in psoriasis: a narrative review.
|
Academic Article
|
Are wash outs needed in clinical trials of topical agents?
|
Academic Article
|
Disease burden and treatment adherence in psoriasis patients.
|
Academic Article
|
Once-daily topical treatment for psoriasis: calcipotriene + betamethasone two-compound topical formulation.
|
Academic Article
|
Treatment sequencing after failure of the first biologic in cost-effectiveness models of psoriasis: a systematic review of published models and clinical practice guidelines.
|
Academic Article
|
Systemic therapies for psoriasis: an evidence-based update.
|
Academic Article
|
Lack of information in current guidelines regarding systemic corticosteroids in inflammatory diseases.
|
Academic Article
|
Systemic corticosteroids are frequently prescribed for psoriasis.
|
Academic Article
|
A review of phosphodiesterase-inhibition and the potential role for phosphodiesterase 4-inhibitors in clinical dermatology.
|
Academic Article
|
Improvement in severe psoriasis associated with isoniazid treatment.
|
Academic Article
|
The quality of life impact of acne and rosacea compared to other major medical conditions.
|
Academic Article
|
Underuse of early follow-up visits: a missed opportunity to improve patients' adherence.
|
Academic Article
|
The economic burden of psoriasis: a systematic literature review.
|
Academic Article
|
Psoriasis: the new and the old.
|
Academic Article
|
Trends in systemic psoriasis treatment therapies from 1993 through 2010.
|
Academic Article
|
Social impact of the burden of psoriasis: effects on patients and practice.
|
Academic Article
|
Calcipotriene 0.005%--betamethasone dipropionate 0.064% ointment versus topical suspension in the treatment of plaque psoriasis: a randomized pilot study of patient preference.
|
Academic Article
|
The cost of biologics for psoriasis is increasing.
|
Academic Article
|
The 5-point Investigator's Global Assessment (IGA) Scale: A modified tool for evaluating plaque psoriasis severity in clinical trials.
|
Academic Article
|
Patterns of medication utilization and costs associated with the use of etanercept, adalimumab, and ustekinumab in the management of moderate-to-severe psoriasis.
|
Academic Article
|
Home ultraviolet light therapy for psoriasis: why patients choose other options.
|
Academic Article
|
Economic and comorbidity burden among moderate-to-severe psoriasis patients with comorbid psoriatic arthritis.
|
Academic Article
|
Psoriasis during pregnancy: characteristics and important management recommendations.
|
Academic Article
|
A guide to prescribing home phototherapy for patients with psoriasis: the appropriate patient, the type of unit, the treatment regimen, and the potential obstacles.
|
Academic Article
|
Inflammatory diseases: Integrating biosimilars into clinical practice.
|
Academic Article
|
Is Safety Psoriasis Patients' Overriding Concern?
|
Academic Article
|
Reasons for Treatment Changes in Patients With Moderate to Severe Psoriasis.
|
Academic Article
|
Immunogenicity of biologic treatments for psoriasis: therapeutic consequences and the potential value of concomitant methotrexate.
|
Academic Article
|
New Frontiers in Psoriasis Treatment.
|
Academic Article
|
Randomized Pilot Clinical Trial of Tofacitinib Solution for Plaque Psoriasis: Challenges of the Intra-Subject Study Design.
|
Academic Article
|
To test or not to test? An updated evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis and psoriatic arthritis.
|
Academic Article
|
Economic and Comorbidity Burden Among Patients with Moderate-to-Severe Psoriasis.
|
Academic Article
|
Even well-controlled psoriasis patients have unmet treatment needs regardless of disease severity.
|
Academic Article
|
The cost-effectiveness of ustekinumab for moderate-to-severe psoriasis.
|
Academic Article
|
Costs of Common Psoriasis Medications, 2010-2014.
|
Academic Article
|
Differences in psoriasis signs and symptom severity between patients with clear and almost clear skin in clinical practice.
|
Academic Article
|
Impact and management of depression in psoriasis patients.
|
Academic Article
|
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study.
|
Academic Article
|
Review of maintenance of response to psoriasis treatments.
|
Academic Article
|
Measurement properties of a patient-reported outcome measure assessing psoriasis severity: The psoriasis symptoms and signs diary.
|
Academic Article
|
Calcipotriene and betamethasone dipropionate for the topical treatment of plaque psoriasis.
|
Academic Article
|
Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis.
|
Academic Article
|
Increasing adherence to topical therapy in psoriasis through use of solution medication.
|
Academic Article
|
Most people with psoriasis or rosacea are not being treated: a large population study.
|
Academic Article
|
Dermatology Residents are Prescribing Tanning Bed Treatment.
|
Academic Article
|
Current challenges and emerging drug delivery strategies for the treatment of psoriasis.
|
Academic Article
|
Tofacitinib improves pruritus and health-related quality of life up to 52 weeks: Results from 2 randomized phase III trials in patients with moderate to severe plaque psoriasis.
|
Academic Article
|
First-Line Fixed-Combination Psoriasis Treatment Is Associated With Lower Healthcare Costs.
|
Academic Article
|
Presenting treatment safety data: subjective interpretations of objective information.
|
Academic Article
|
Current status and future prospects for biologic treatments of psoriasis.
|
Academic Article
|
A boxed warning for inadequate psoriasis treatment.
|
Academic Article
|
Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial.
|
Academic Article
|
Relative versus absolute risk of comorbidities in patients with psoriasis.
|
Academic Article
|
Erythrodermic psoriasis and severe hypotension requiring intensive care unit hospitalization: Poor treatment outcome as a result of poor adherence.
|
Academic Article
|
Advances in Psoriasis.
|
Academic Article
|
Oral tofacitinib for the treatment of adults with moderate to severe chronic plaque psoriasis.
|
Academic Article
|
Assessing the overall benefit of a medication: cumulative benefit of secukinumab over time in patients with moderate-to-severe plaque psoriasis.
|
Academic Article
|
Dermatologists: Collaborating With Payers to Optimize Coverage Policies.
|
Academic Article
|
Hypothyroidism in Patients with Psoriasis or Rosacea: A Large Population Study.
|
Academic Article
|
Cost of diagnosing psoriasis and rosacea for dermatologists versus primary care physicians.
|
Academic Article
|
Hypothyroidism in Patients with Psoriasis or Rosacea: A Large Population Study.
|
Academic Article
|
Psoriasis, Depression, and Inflammatory Overlap: A Review.
|
Academic Article
|
Desoximetasone 0.25% spray, adrenal suppression and efficacy in extensive plaque psoriasis.
|
Academic Article
|
Topical 0.25% desoximetasone spray efficacy for moderate to severe plaque psoriasis: a randomized clinical trial.
|
Academic Article
|
Evolution in psoriasis management.
|
Academic Article
|
Economic burden of comorbidities in psoriasis patients in the United States: results from a retrospective U.S. database.
|
Academic Article
|
Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease.
|
Academic Article
|
Budget impact model in moderate-to-severe psoriasis vulgaris assessing effects of calcipotriene and betamethasone dipropionate foam on per-patient standard of care costs.
|
Academic Article
|
An Anchoring-Based Intervention to Increase Patient Willingness to Use Injectable Medication in Psoriasis.
|
Academic Article
|
Comorbidities in patients with psoriasis: The role of the dermatologist.
|
Academic Article
|
Healthcare costs in psoriasis and psoriasis sub-groups over time following psoriasis diagnosis.
|
Academic Article
|
Real-world burden of comorbidities in US patients with psoriasis.
|
Academic Article
|
Utility of boron in dermatology.
|
Academic Article
|
Treatment Changes in Patients With Moderate to Severe Psoriasis: A Retrospective Chart Review.
|
Academic Article
|
Severe and acute complications of biologics in psoriasis.
|
Academic Article
|
Implications of treatment resistant severe psoriasis for benchmarking quality of care.
|
Academic Article
|
Calcipotriene/betamethasone dipropionate for the treatment of psoriasis vulgaris: an evidence-based review.
|
Academic Article
|
Rethinking the costs of psoriasis management.
|
Academic Article
|
Treating Moderate-to-Severe Plaque Psoriasis With Guselkumab: A Review of Phase II and Phase III Trials.
|
Academic Article
|
Adherence to biologics in patients with psoriasis.
|
Academic Article
|
Biologics monitoring: incongruity between recommendations and clinician monitoring trends.
|
Academic Article
|
Secukinumab improves scalp pain, itching, scaling and quality of life in patients with moderate-to-severe scalp psoriasis.
|
Academic Article
|
The efficacy of short-term clobetasol lotion in the treatment of scalp psoriasis.
|
Academic Article
|
Advances in treating psoriasis in the elderly with small molecule inhibitors.
|
Academic Article
|
Higher Psoriasis Skin Clearance Is Associated with Lower Annual Indirect Costs in the United States: A Post Hoc Analysis from the CLEAR Study.
|
Academic Article
|
Adherence and resource use among psoriasis patients treated with biologics.
|
Academic Article
|
Comparison of the cost-effectiveness of biologic drugs used for moderate-to-severe psoriasis treatment in the United States.
|
Academic Article
|
Patients preferences for different corticosteroid vehicles are highly variable.
|
Academic Article
|
Web app based patient education in psoriasis - a randomized controlled trial.
|
Academic Article
|
Comment on "Serious infections among a large cohort of subjects with systemically treated psoriasis".
|
Academic Article
|
Effect of Prior Biologic Use on Cost-Effectiveness of Brodalumab vs. Ustekinumab for Treatment of Moderate-to-Severe Psoriasis in the United States.
|
Academic Article
|
The budget impact of brodalumab for the treatment of moderate-to-severe plaque psoriasis on US commercial health plans.
|
Academic Article
|
Cost Per Additional Responder Associated With Ixekizumab and Etanercept in the Treatment of Moderate-to-Severe Psoriasis.
|
Academic Article
|
The Challenge of Managing Psoriasis: Unmet Medical Needs and Stakeholder Perspectives.
|
Academic Article
|
Clinical potential of brodalumab in the management of psoriasis: the evidence to date.
|
Academic Article
|
Risankizumab for psoriasis.
|
Academic Article
|
ProvenCare-Psoriasis: A disease management model to optimize care.
|
Academic Article
|
Economic Impact of Above-Label Dosing with Etanercept, Adalimumab, or Ustekinumab in Patients with Psoriasis.
|
Academic Article
|
Pharmacokinetics of tazarotene and acitretin in psoriasis.
|
Academic Article
|
Real-world US healthcare costs of psoriasis for biologic-naive patients initiating apremilast or biologics.
|
Academic Article
|
A systematic review of herpes zoster incidence and consensus recommendations on vaccination in adult patients on systemic therapy for psoriasis or psoriatic arthritis: From the Medical Board of the National Psoriasis Foundation.
|
Academic Article
|
Targeting p19 as a treatment option for psoriasis: an evidence-based review of guselkumab.
|
Academic Article
|
Assessing Efficacy and the Speed of Response in Psoriasis Treatment.
|
Academic Article
|
Psychosocial impact of psoriasis: a review for dermatology residents.
|
Academic Article
|
Patient-reported outcomes are important elements of psoriasis treatment decision making: A discrete choice experiment survey of dermatologists in the United States.
|
Academic Article
|
Gastrointestinal Signs and Symptoms Related to Inflammatory Bowel Disease in Patients With Moderate-to-Severe Psoriasis
|
Academic Article
|
Mechanisms of microbial pathogenesis and the role of the skin microbiome in psoriasis: A review.
|
Academic Article
|
Incidence rates of comorbidities among patients with psoriasis in the United States.
|
Academic Article
|
A safety review of recent advancements in the treatment of psoriasis: analysis of clinical trial safety data.
|
Academic Article
|
Investigational drugs in phase II clinical trials for moderate to severe plaque psoriasis - potential new treatments on the horizon.
|
Academic Article
|
Tildrakizumab: A Review of Phase II and III Clinical Trials.
|
Academic Article
|
Adherence to a novel home phototherapy system with integrated features.
|
Academic Article
|
Can We Tell Patients That IL-23 and TNF-a Inhibition Are "Natural" Ways to Treat Psoriasis?
|
Academic Article
|
Secukinumab for psoriasis in a patient with hepatitis B.
|
Academic Article
|
Pharmacotherapeutic strategies for standard treatment-resistant psoriasis.
|
Academic Article
|
Is topical treatment effective for psoriasis in patients who failed topical treatment?
|
Academic Article
|
Current biological therapies for use in HIV-positive patients with psoriasis: case report of gesulkumab used and review.
|
Academic Article
|
Diet and psoriasis.
|
Academic Article
|
A novel ultraviolet B home phototherapy system: Efficacy, tolerability, adherence, and satisfaction.
|
Academic Article
|
The journey for US psoriasis patients prescribed a topical: a retrospective database evaluation of patient progression to oral and/or biologic treatment.
|
Academic Article
|
Current pharmacological treatment guidelines for psoriasis and psoriatic arthritis.
|
Academic Article
|
Optimizing presentation of expected treatment outcomes.
|
Academic Article
|
Medication adherence and persistence in patients with rheumatoid arthritis, psoriasis, and psoriatic arthritis: a systematic literature review.
|
Academic Article
|
Health Care Utilization and Cost Associated with Biologic Treatment Patterns Among Patients with Moderate to Severe Psoriasis: Analyses from a Large U.S. Claims Database.
|
Academic Article
|
Psoriasis and Atopic Dermatitis "Resistant" to Topical Treatment Responds Rapidly to Topical Desoximetasone Spray.
|
Academic Article
|
Psoriasis therapy and aortic inflammation - translating statistical to clinical significance.
|
Academic Article
|
Treatment patterns among patients with psoriasis using a large national payer database in the United States: a retrospective study.
|
Academic Article
|
Choice Overload in Systemic Psoriasis Therapy.
|
Academic Article
|
Pregnancy outcomes in patients with psoriasis, psoriatic arthritis, or axial spondyloarthritis receiving ixekizumab.
|
Academic Article
|
Should the presence of psoriatic arthritis change how we manage psoriasis?
|
Academic Article
|
Refractory Pediatric Psoriasis and Atopic Dermatitis: The Importance of Therapeutical Adherence and Biological Management.
|
Academic Article
|
Treatment Adherence and Persistence of Seven Commonly Prescribed Biologics for Moderate to Severe Psoriasis and Psoriatic Arthritis in a U.S. Commercially Insured Population.
|
Academic Article
|
Correlation Between Change in Psoriasis Area and Severity Index and Dermatology Life Quality Index in Patients with Psoriasis: Pooled Analysis from Four Phase 3 Clinical Trials of Secukinumab.
|
Academic Article
|
Tildrakizumab: interpreting the data.
|
Academic Article
|
Association between menopausal hormone therapy and incidence of psoriasis: a secondary analysis from the Women's Health Initiative randomized clinical trials.
|
Academic Article
|
Psoriasis Severity and Cardiometabolic Risk Factors in a Representative US National Study.
|
Academic Article
|
Studies of single and multiple institutions may illustrate different treatment practices for psoriasis.
|
Academic Article
|
Topical calcipotriol plus betamethasone dipropionate for the treatment of plaque psoriasis: a drug evaluation.
|
Academic Article
|
Clinical implications and predictive values of early PASI responses to tildrakizumab in patients with moderate-to-severe plaque psoriasis.
|